Opsonic alpha2 surface binding glycoprotein therapy during sepsis. - Wikidata - wikimedia - TriplyDB

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

http://www.wikidata.org/entity/Q45712438

about

Decreased plasma fibronectin concentrations in preterm infants with septicaemia.Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.Reticuloendothelial function in coeliac disease and ulcerative colitis.Diagnosing malnutrition.Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma.Fibronectin in fulminant hepatic failure.Augmentation of human monocyte opsonin-independent phagocytosis by fragments of human plasma fibronectin.Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation.Circulating immunoreactive and bioassayable opsonic plasma fibronectin during experimental tumour growth Fibronectin as an opsonic regulator of monocyte phagocytosis.Fibronectin: applications to clinical medicine.Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits.Fibronectin binding to protein A-containing staphylococci.Plasma fibronectin is initially decreased during septicemia.Symposium report blood culture--current state and future prospects. Abstracts

P2860

Q33623347-627B081B-5274-4CBD-81ED-6640A5A82A3B Q33832980-DC9C631E-4095-43A0-8232-4FBB2779DF89 Q34495892-03ABA6A1-F9E3-4383-8061-EA405A0EEF26 Q34533419-45BAB7C1-63C7-4B9D-BA7A-BD3EE8EDDA1C Q34598422-2C6EDE4C-286E-4C2A-92EB-1B7525A11010 Q34764037-3D4FDFFC-A938-45DF-9FCD-DB0B10E7AF68 Q35380896-C6B0DF7D-49D7-4EDE-809A-60445A542219 Q35815945-5ED9CD63-C01A-4DAD-A9AF-E5D5CEE8F673 Q36044047-C71FD0B8-9A90-4377-B650-15848C5993C6 Q39529491-81947C17-4BAF-4A33-B07D-9E101CAEA698 Q39727785-C31AD5F0-08FC-4C52-AB3C-BAD4C14426D8 Q40597978-EBB78682-5260-45F1-A880-3F6ACBCA7468 Q40611648-2547AD48-AA2E-445E-8B83-2F1E14DF6698 Q44979205-6F30A8F6-96F5-436B-BB7E-68CBC5E53E8E Q57657165-75F353EE-B0B7-405D-AB95-BBA5FB695F14

P2860

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

http://www.wikidata.org/entity/Q45712438

description

1978 nî lūn-bûn

@nan

1978年の論文

@ja

1978年学术文章

@wuu

1978年学术文章

@zh

1978年学术文章

@zh-cn

1978年学术文章

@zh-hans

1978年学术文章

@zh-my

1978年学术文章

@zh-sg

1978年學術文章

@yue

1978年學術文章

@zh-hant

name

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

@en

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

@nl

type

label

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

@en

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

@nl

prefLabel

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

@en

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

@nl

P1433

Q45712438-8B7EC262-AE81-4DC5-8F32-70A02772B1D8

P1476

Q45712438-99D009B2-770A-45DB-BC25-364F48DEE799

P2093

Q45712438-5661E21E-522D-4C40-B460-2547912314BF

Q45712438-56E28718-8009-4FD2-9085-55A215DF1BDC

Q45712438-814009DD-C37C-4974-9C8E-8098A631B648

Q45712438-C5D250E2-BBAE-4C14-B8AD-A397311A22C5

Q45712438-D45ED549-F92A-42A7-B9BF-BCEEFA821827

P2860

Q45712438-49D9CB29-8AAC-43F2-B41A-BD7A26D25002

Q45712438-6BC1EC87-087C-4E95-865E-F1312E7D48C2

Q45712438-70554570-F816-45C0-9CD6-921B2824D986

Q45712438-7DF0CB8D-75BF-4CE9-8DA6-24A20C91FC06

Q45712438-A10FC99E-6692-4849-841F-107029A94C1D

Q45712438-B416A18D-56D4-4A19-B2B1-C0687BA81247

Q45712438-D6154695-168E-43B6-A420-C4677D474A85

Q45712438-D6B750BF-3F38-4B75-8A17-78692491F369

Q45712438-D9D00B5F-FF58-4228-AEE0-00C4C9F9F0CB

Q45712438-DCBA86B4-3BC1-4484-839E-95306CE44676

P304

Q45712438-CC64A581-AF18-44AD-AD2E-8810D4BB516F

P31

Q45712438-27DD258D-F88F-4D80-AB55-F5AB02421F77

P356

Q45712438-B759DD4B-5BEF-409B-8B7D-27107DD3564A

P407

Q45712438-9431F6D4-5462-429B-B55F-A40C856380BB

P433

Q45712438-3C1105BA-BBE5-44B7-9716-75CB0E877B7B

P478

Q45712438-66284685-C0FB-4774-A7F9-F1744C404436

P577

Q45712438-F2C8D161-6305-4A99-A8BF-9D24F74121EB

P5875

Q45712438-7B92F6D0-8627-417C-89C7-55FB3A46083B

P698

Q45712438-4AD637B0-EAE5-404B-9C31-1D84AE7EC652

P921

Q45712438-349876B6-7D2F-440A-A402-10B206D605D9

P932

Q45712438-60CA1D9B-02C0-410F-B9F4-9F2CFE6ABA5F

P356

00000658-197810000-00009

P1433

Annals of Surgery

P1476

Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

@en

P2093

Bernard H

http://www.w3.org/2001/XMLSchema#string

Blumenstock FA

http://www.w3.org/2001/XMLSchema#string

Powers SR Jr

http://www.w3.org/2001/XMLSchema#string

Saba TM

http://www.w3.org/2001/XMLSchema#string

Scovill WA

http://www.w3.org/2001/XMLSchema#string

P2860

Intravascular microaggregation and the respiratory distress syndromes.

The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. II. The possible role of the reticulo-endothelial system in resistance to each type of shock.

Deficits in reticuloendothelial humoral control mechanisms in patients after trauma.

Biochemical and immunological characterization of human opsonic alpha2SB glycoprotein: its identity with cold-insoluble globulin.

Purification of alpha-2-opsonic protein from human serum and its measurement by immunoassay.

Immunohistochemical demonstration of the reticuloendothelial clearance of circulating fibrin aggregates.

Pulmonary damage following pulmonary microembolism in the dog. Effect of various types of treatment.

Prevention of liver reticuloendothelial systemic host defense failure after surgery by intravenous opsonic glycoprotein therapy.

Disturbances in circulating opsonic activity in man after operative and blunt trauma.

Deficiency of plasma humoral recognition factor activity following burn injury.

P304

521-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00000658-197810000-00009

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

188

http://www.w3.org/2001/XMLSchema#string

P577

1978-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240036884

http://www.w3.org/2001/XMLSchema#string

P698

697436

http://www.w3.org/2001/XMLSchema#string

P921

P932

1396858

http://www.w3.org/2001/XMLSchema#string